Saturday, September 26, 2026
25.9 C
Bengaluru

The Semaglutide Story: How One Molecule Re‑wired Obesity, Patents and Pharma Profits

1. From Gut Hormone to “Wonder Drug”

If you strip away the hype, semaglutide is simply a clever copy of a natural hormone that tells the body “you’ve eaten enough.”[1]
In the 1980s and 1990s, researchers discovered that the gut hormone GLP‑1 could lower blood sugar, slow digestion and curb appetite, but the natural hormone disappeared from the body within minutes.[2][3]

So Novo Nordisk chemists spent years “armouring” GLP‑1—tweaking its structure so it survived longer in the bloodstream and could be given as a weekly injection instead of a constant drip.[4][5]
One of those tweaked versions was semaglutide, designed to stay active for around a week, which made it practical for real‑world use in diabetes and, later, obesity.[6][7]

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

Topics

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...
spot_img

Related Articles

spot_imgspot_img